Search tips
Search criteria 


Logo of jrsocmedLink to Publisher's site
J R Soc Med. 1998 September; 91(9): 475–478.
PMCID: PMC1296875

Hormone replacement therapy and cardioprotection in the elderly.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (595K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Rich-Edwards JW, Manson JE, Hennekens CH, Buring JE. The primary prevention of coronary heart disease in women. N Engl J Med. 1995 Jun 29;332(26):1758–1766. [PubMed]
  • Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Willett WC, Rosner B, Speizer FE, Hennekens CH. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med. 1996 Aug 15;335(7):453–461. [PubMed]
  • Collins P, Rosano GM, Sarrel PM, Ulrich L, Adamopoulos S, Beale CM, McNeill JG, Poole-Wilson PA. 17 beta-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation. 1995 Jul 1;92(1):24–30. [PubMed]
  • Kawano H, Motoyama T, Kugiyama K, Hirashima O, Ohgushi M, Fujii H, Ogawa H, Yasue H. Gender difference in improvement of endothelium-dependent vasodilation after estrogen supplementation. J Am Coll Cardiol. 1997 Oct;30(4):914–919. [PubMed]
  • Samaan SA, Crawford MH. Estrogen and cardiovascular function after menopause. J Am Coll Cardiol. 1995 Nov 15;26(6):1403–1410. [PubMed]
  • Pines A, Mijatovic V, van der Mooren MJ, Kenemans P. Hormone replacement therapy and cardioprotection: basic concepts and clinical considerations. Eur J Obstet Gynecol Reprod Biol. 1997 Feb;71(2):193–197. [PubMed]
  • Alfie J, Lugones L, Belardo A, Tutzer M, Galarza CR, Waisman GD, Cámera MI. Hemodynamic effects of transdermal estradiol alone and combined with norethisterone acetate. Maturitas. 1997 Jun;27(2):163–169. [PubMed]
  • Mosca L, Manson JE, Sutherland SE, Langer RD, Manolio T, Barrett-Connor E. Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Writing Group. Circulation. 1997 Oct 7;96(7):2468–2482. [PubMed]
  • Handa VL, Landerman R, Hanlon JT, Harris T, Cohen HJ. Do older women use estrogen replacement? Data from the Duke Established Populations for Epidemiologic Studies of the Elderly (EPESE) J Am Geriatr Soc. 1996 Jan;44(1):1–6. [PubMed]
  • Salamone LM, Pressman AR, Seeley DG, Cauley JA. Estrogen replacement therapy. A survey of older women's attitudes. Arch Intern Med. 1996 Jun 24;156(12):1293–1297. [PubMed]
  • Miller KL. Hormone replacement therapy in the elderly. Clin Obstet Gynecol. 1996 Dec;39(4):912–932. [PubMed]
  • Ettinger B, Friedman GD, Bush T, Quesenberry CP., Jr Reduced mortality associated with long-term postmenopausal estrogen therapy. Obstet Gynecol. 1996 Jan;87(1):6–12. [PubMed]
  • Sidney S, Petitti DB, Quesenberry CP., Jr Myocardial infarction and the use of estrogen and estrogen-progestogen in postmenopausal women. Ann Intern Med. 1997 Oct 1;127(7):501–508. [PubMed]
  • Psaty BM, Heckbert SR, Atkins D, Lemaitre R, Koepsell TD, Wahl PW, Siscovick DS, Wagner EH. The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women. Arch Intern Med. 1994 Jun 27;154(12):1333–1339. [PubMed]
  • Bush TL, Barrett-Connor E, Cowan LD, Criqui MH, Wallace RB, Suchindran CM, Tyroler HA, Rifkind BM. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation. 1987 Jun;75(6):1102–1109. [PubMed]
  • Falkeborn M, Persson I, Adami HO, Bergström R, Eaker E, Lithell H, Mohsen R, Naessén T. The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement. Br J Obstet Gynaecol. 1992 Oct;99(10):821–828. [PubMed]
  • Folsom AR, Mink PJ, Sellers TA, Hong CP, Zheng W, Potter JD. Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women. Am J Public Health. 1995 Aug;85(8 Pt 1):1128–1132. [PubMed]
  • Manolio TA, Furberg CD, Shemanski L, Psaty BM, O'Leary DH, Tracy RP, Bush TL. Associations of postmenopausal estrogen use with cardiovascular disease and its risk factors in older women. The CHS Collaborative Research Group. Circulation. 1993 Nov;88(5 Pt 1):2163–2171. [PubMed]
  • White MM, Zamudio S, Stevens T, Tyler R, Lindenfeld J, Leslie K, Moore LG. Estrogen, progesterone, and vascular reactivity: potential cellular mechanisms. Endocr Rev. 1995 Dec;16(6):739–751. [PubMed]
  • Gruchow HW, Anderson AJ, Barboriak JJ, Sobocinski KA. Postmenopausal use of estrogen and occlusion of coronary arteries. Am Heart J. 1988 May;115(5):954–963. [PubMed]
  • Hong MK, Romm PA, Reagan K, Green CE, Rackley CE. Effects of estrogen replacement therapy on serum lipid values and angiographically defined coronary artery disease in postmenopausal women. Am J Cardiol. 1992 Jan 15;69(3):176–178. [PubMed]
  • Newton KM, LaCroix AZ, McKnight B, Knopp RH, Siscovick DS, Heckbert SR, Weiss NS. Estrogen replacement therapy and prognosis after first myocardial infarction. Am J Epidemiol. 1997 Feb 1;145(3):269–277. [PubMed]
  • Sullivan JM, Vander Zwaag R, Hughes JP, Maddock V, Kroetz FW, Ramanathan KB, Mirvis DM. Estrogen replacement and coronary artery disease. Effect on survival in postmenopausal women. Arch Intern Med. 1990 Dec;150(12):2557–2562. [PubMed]
  • Sullivan JM, El-Zeky F, Vander Zwaag R, Ramanathan KB. Effect on survival of estrogen replacement therapy after coronary artery bypass grafting. Am J Cardiol. 1997 Apr 1;79(7):847–850. [PubMed]
  • O'Keefe JH, Jr, Kim SC, Hall RR, Cochran VC, Lawhorn SL, McCallister BD. Estrogen replacement therapy after coronary angioplasty in women. J Am Coll Cardiol. 1997 Jan;29(1):1–5. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press